IndiaTickerPendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Company dossier
Panacea Biotec
NSE:PANACEABIO · ISIN INE922B01023
- Close
- ₹423.85 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Panacea Biotec
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI LODR Regulations')BSE · exchange filing · pdf
Source filing Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Panacea Biotec LimitedNSE · exchange filing · pdf
Archived filing Panacea Biotec Ltd - 531349 - Updates In Relation To Receipt Of Four Awards Dated March 19, 2026 From The Presiding Officer (In The Rank Of Additional District Judge) Of Industrial Tribunal, S.A.S. Nagar, MohaliBSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Disclosures under Reg. 10(7) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Certificate under SEBI (Depositories and Participants) Regulations, 2018 - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Updates - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Pendency of Litigation(s)/dispute(s) or the outcome impacting the Company - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Updates In Relation To Receipt Of Four Awards Dated March 19, 2026 From The Presiding Officer (In The Rank Of Additional District Judge) Of Industrial Tribunal, S.A.S. Nagar, MohaliBSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Demat Status Report For The Month Of June 2026BSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018BSE · exchange filing · pdf
Source filing Trading Window - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Closure of Trading WindowBSE · financial results · pdf
Source filing Disclosure under SEBI Takeover Regulations - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Disclosures under Reg. 10(6) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Press Release - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Details Of Shares Dematerialized During May 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018BSE · exchange filing · pdf
Source filing Disclosure under SEBI Takeover Regulations - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing Updates - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · financial results · pdf
Source filing Copy of Newspaper Publication - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Audited Financial Results For Quarter And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Panacea Biotec Ltd - 531349 - Board Meeting Outcome for 1. Standalone And Consolidated Audited Financial Results For The Quarter And Financial Year Ended 31.03.2026
2. Passing Over Of Dividend For The Financial Year 2025-26
3. Appointment Of Mr. Rajinder Singh Manku As Non-Executive Independent DirectorBSE · financial results · pdf
Source filing Panacea Biotec Ltd - 531349 - Announcement under Regulation 30 (LODR)-Change in DirectorateBSE · exchange filing · pdf
Source filing Outcome of Board Meeting - Panacea Biotec LimitedNSE · financial results · pdf
Source filing Change in Director(s) - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 Read With Para A Of Part A Of Schedule III Of The Said RegulationsBSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing General Updates - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Update on board meetingBSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Board Meeting Intimation for Inter-Alia Approving Standalone And Consolidated Audited Financial Results For Quarter And Financial Year Ended March 31, 2026BSE · financial results · pdf
Source filing Panacea Biotec Ltd - 531349 - Details Of Shares Dematerialized During April 2026 Under Regulation 74(5) Of The SEBI (Depositories And Participants) Regulations, 2018BSE · exchange filing · pdf
Source filing Updates - Panacea Biotec LimitedNSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Intimation Of Fire Incident At Oncology Facility Of The Company'S Wholly Owned Subsidiary, Panacea Biotec Pharma Limited At Baddi, Himachal PradeshBSE · exchange filing · pdf
Source filing Panacea Biotec Ltd - 531349 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing